Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
434.03
+7.92 (1.86%)
At close: Oct 15, 2026, 4:00 PM EDT
434.01
-0.02 (0.00%)
After-hours: Oct 15, 2026, 7:57 PM EDT
Amgen Revenue
Amgen had revenue of $10.05B in the quarter ending June 30, 2026, with 9.53% growth. This brings the company's revenue in the last twelve months to $38.10B, up 9.10% year-over-year. In the year 2025, Amgen had annual revenue of $36.75B with 9.95% growth. That makes Amgen the 355th largest company in the world by revenue and 126th in the United States.
Revenue (ttm)
$38.10B
Revenue Growth
+9.10%
P/S Ratio
6.16
Revenue / Employee
$1,209,365
Employees
31,500
Market Cap
234.65B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.75B | 3.33B | 9.95% |
| Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
| Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
| Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
| Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
| Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
| Dec 31, 2019 | 23.36B | -385.00M | -1.62% |
| Dec 31, 2018 | 23.75B | 898.00M | 3.93% |
| Dec 31, 2017 | 22.85B | -142.00M | -0.62% |
| Dec 31, 2016 | 22.99B | 1.33B | 6.14% |
| Dec 31, 2015 | 21.66B | 1.60B | 7.97% |
| Dec 31, 2014 | 20.06B | 1.39B | 7.43% |
| Dec 31, 2013 | 18.68B | 1.41B | 8.17% |
| Dec 31, 2012 | 17.27B | 1.68B | 10.80% |
| Dec 31, 2011 | 15.58B | 529.00M | 3.51% |
| Dec 31, 2010 | 15.05B | 411.00M | 2.81% |
| Dec 31, 2009 | 14.64B | -361.00M | -2.41% |
| Dec 31, 2008 | 15.00B | 232.00M | 1.57% |
| Dec 31, 2007 | 14.77B | 503.00M | 3.53% |
| Dec 31, 2006 | 14.27B | 1.84B | 14.79% |
| Dec 31, 2005 | 12.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 99.34B |
| Merck & Co. | 66.57B |
| AbbVie | 64.39B |
| Pfizer | 63.70B |
| AstraZeneca | 61.37B |
| Novartis AG | 56.69B |
| Sanofi | 55.89B |
| Novo Nordisk | 50.34B |
AMGN News
- 8 hours ago - These Consumer Stocks Are Getting a Lift as Investors Rotate Out of Tech - Investopedia
- 11 hours ago - Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets - Market Watch
- 2 days ago - Amgen price target lowered to $378 from $388 at Guggenheim - TheFly
- 3 days ago - Amgen price target lowered to $415 from $450 at BMO Capital - TheFly
- 3 days ago - Amgen price target raised to $328 from $317 at BofA - TheFly
- 3 days ago - Amgen price target lowered to $430 from $435 at Wells Fargo - TheFly
- 6 days ago - Amgen price target raised to $470 from $430 at UBS - TheFly
- 7 days ago - Amgen price target raised to $430 from $400 at RBC Capital - TheFly